
Pharmaceutical Contract Packaging Market Report and Forecast 2025-2034
Description
The global pharmaceutical contract packaging market size was valued at USD 24.18 Billion in 2024 . The market is further projected to grow at a CAGR of 7.50% between 2025 and 2034, reaching a value of USD 49.84 Billion by 2034 .
Pharmaceutical contract packaging is the outsourcing for secondary activities such as product packaging and labelling to third parties. A contract pharmaceutical packager provides services, installations, as well as equipment, ranging from drug packaging design to the testing of the packaged drug. Pharmaceutical companies employ secondary packaging companies because it is more reliable, profitable, and helps them improve customer satisfaction and provides brand recognition.
A growing focus on sustainability is likely to drive the use of recyclable and biodegradable materials in pharmaceutical packaging products, which is predicted to aid in pharmaceutical contract packaging market growth. The thriving demand for convenient packaging, which makes it easier to manage the storage and use of pharmaceuticals, is expected to have a positive impact on the pharmaceutical contract packaging market outlook.
Key Trends and Developments
Growing adoption of smart packaging technologies, rising environmental concerns, and increasing need for reliable packaging of medicines are increasing the demand for pharmaceutical contract packaging solutions
Global Pharmaceutical Contract Packaging Market Trends
One of the main factors that results in pharmaceutical contract packaging market development is the introduction of strict rules and regulations for product labelling. Moreover, pharmaceutical contract packaging companies can use different types of packaging and can easily solve problems arising from diverse packaging requirements, compared to drug makers. These manufacturers invest in research and development programs to improve the quality of their products.
Moreover, these organisations also help pharmaceutical firms establish a dynamic platform for distributing drugs and medical devices in various regions. Furthermore, the increasing use of smart packaging solutions, such as QR codes, is expected to provide a positive pharmaceutical contract packaging market outlook.
Market Segmentation
Global Pharmaceutical Contract Packaging Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Industry
The sterile product segment accounted for the largest share in pharmaceutical contract packaging market. Sterile products are those that are free from any viable microorganisms, such as injectables, ophthalmics, inhalables, and biologics. Sterile products require a high level of quality and safety, as they are directly administered to the patients. Therefore, the demand for sterile contract packaging is high, as it ensures the sterility, stability, and integrity of the products.
On the other hand, non-sterile products are those that do not require sterility, such as oral solids, oral liquids, topical creams, and gels. Non-sterile products require a lower level of quality and safety, as they are not directly administered to the patients. As per pharmaceutical contract packaging market analysis, the demand for non-sterile contract packaging is also high, as it offers flexibility to pharmaceutical companies and can be customised.
Plastic bottles will bolster the pharmaceutical contract packaging market growth as they are low in cost and easy to handle
The plastic bottles segment is expected to increase the pharmaceutical contract packaging market value as they are widely used for oral solid and liquid formulations, such as tablets, capsules, syrups, and suspensions. Plastic bottles also offer advantages such as low cost, high durability, easy handling, and recyclability.
Caps and closures are used to seal and protect the pharmaceutical products from contamination, tampering, and leakage. Caps and closures include screw caps, flip-top caps, child-resistant caps, tamper-evident caps, and dispensing caps. The caps and closures segment is expected to witness a growing pharmaceutical contract packaging market share due to the increasing demand for safe and secure packaging, the growing preference for convenience and ease of use, and the emergence of smart and interactive caps and closures.
Prefilled syringes are used for injectable formulations, such as vaccines, biologics, and biosimilars. Prefilled syringes consist of a glass or plastic barrel, a plunger, a needle, and a cap. Prefilled syringes are the fastest growing segment in the pharmaceutical contract packaging market as they offer advantages such as ease of administration, dosage accuracy, reduced wastage, and enhanced safety.
Furthermore, parenteral vials and ampoules are made of glass or plastic and have a rubber stopper and a metal seal. Parenteral vials and ampoules offer benefits such as sterility, stability, and compatibility. The pharmaceutical contract packaging market projects that share of parenteral vials and ampoules segment will grow at a steady rate. The growth of this segment can be attributed to the increasing demand for sterile and aseptic packaging, the rising incidence of infectious and chronic diseases, and the expansion of the biosimilar market.
Competitive Landscape
Market players are providing contract packaging services to pharmaceutical manufacturers, ensuring efficient and reliable packaging solutions for medicines and healthcare products.
Other key players in the global pharmaceutical contract packaging market include Sharp Corporation, among others.
Global Pharmaceutical Contract Packaging Market Analysis by Region
United States leads the market share due to rising healthcare spending, which creates a demand for packaging solutions
The United States represents the world's largest market in pharmaceutical contract packaging, followed by China and India. The tremendous growth of pharmaceutical contract packaging market in United States is majorly driven by the rising healthcare spending, increasing geriatric population, and the increasing value of pharmaceutical exports. The growth is further driven by the high demand for innovative and specialised packaging solutions, the presence of leading pharmaceutical companies and contract packagers, and the stringent regulatory standards for quality and safety.
On the other hand, the pharmaceutical contract packaging market size in China is driven by the rapid growth of the pharmaceutical industry, the increasing outsourcing of packaging services, and the rising demand for biologics and biosimilars. According to pharmaceutical contract packaging market report, the Indian market is driven by the low-cost advantage, the availability of skilled labour, the increasing exports of generic drugs, and the growing domestic demand for pharmaceutical products.
Pharmaceutical contract packaging is the outsourcing for secondary activities such as product packaging and labelling to third parties. A contract pharmaceutical packager provides services, installations, as well as equipment, ranging from drug packaging design to the testing of the packaged drug. Pharmaceutical companies employ secondary packaging companies because it is more reliable, profitable, and helps them improve customer satisfaction and provides brand recognition.
A growing focus on sustainability is likely to drive the use of recyclable and biodegradable materials in pharmaceutical packaging products, which is predicted to aid in pharmaceutical contract packaging market growth. The thriving demand for convenient packaging, which makes it easier to manage the storage and use of pharmaceuticals, is expected to have a positive impact on the pharmaceutical contract packaging market outlook.
Key Trends and Developments
Growing adoption of smart packaging technologies, rising environmental concerns, and increasing need for reliable packaging of medicines are increasing the demand for pharmaceutical contract packaging solutions
Global Pharmaceutical Contract Packaging Market Trends
One of the main factors that results in pharmaceutical contract packaging market development is the introduction of strict rules and regulations for product labelling. Moreover, pharmaceutical contract packaging companies can use different types of packaging and can easily solve problems arising from diverse packaging requirements, compared to drug makers. These manufacturers invest in research and development programs to improve the quality of their products.
Moreover, these organisations also help pharmaceutical firms establish a dynamic platform for distributing drugs and medical devices in various regions. Furthermore, the increasing use of smart packaging solutions, such as QR codes, is expected to provide a positive pharmaceutical contract packaging market outlook.
Market Segmentation
Global Pharmaceutical Contract Packaging Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Industry
- Small Molecule
- Biopharmaceutical
- Vaccine
- Sterile
- Non-Sterile
- Plastic Bottles
- Caps and Closures
- Blister Packs
- Prefilled Syringes
- Parenteral Vials and Ampoules
- United States
- Europe
- China
- India
The sterile product segment accounted for the largest share in pharmaceutical contract packaging market. Sterile products are those that are free from any viable microorganisms, such as injectables, ophthalmics, inhalables, and biologics. Sterile products require a high level of quality and safety, as they are directly administered to the patients. Therefore, the demand for sterile contract packaging is high, as it ensures the sterility, stability, and integrity of the products.
On the other hand, non-sterile products are those that do not require sterility, such as oral solids, oral liquids, topical creams, and gels. Non-sterile products require a lower level of quality and safety, as they are not directly administered to the patients. As per pharmaceutical contract packaging market analysis, the demand for non-sterile contract packaging is also high, as it offers flexibility to pharmaceutical companies and can be customised.
Plastic bottles will bolster the pharmaceutical contract packaging market growth as they are low in cost and easy to handle
The plastic bottles segment is expected to increase the pharmaceutical contract packaging market value as they are widely used for oral solid and liquid formulations, such as tablets, capsules, syrups, and suspensions. Plastic bottles also offer advantages such as low cost, high durability, easy handling, and recyclability.
Caps and closures are used to seal and protect the pharmaceutical products from contamination, tampering, and leakage. Caps and closures include screw caps, flip-top caps, child-resistant caps, tamper-evident caps, and dispensing caps. The caps and closures segment is expected to witness a growing pharmaceutical contract packaging market share due to the increasing demand for safe and secure packaging, the growing preference for convenience and ease of use, and the emergence of smart and interactive caps and closures.
Prefilled syringes are used for injectable formulations, such as vaccines, biologics, and biosimilars. Prefilled syringes consist of a glass or plastic barrel, a plunger, a needle, and a cap. Prefilled syringes are the fastest growing segment in the pharmaceutical contract packaging market as they offer advantages such as ease of administration, dosage accuracy, reduced wastage, and enhanced safety.
Furthermore, parenteral vials and ampoules are made of glass or plastic and have a rubber stopper and a metal seal. Parenteral vials and ampoules offer benefits such as sterility, stability, and compatibility. The pharmaceutical contract packaging market projects that share of parenteral vials and ampoules segment will grow at a steady rate. The growth of this segment can be attributed to the increasing demand for sterile and aseptic packaging, the rising incidence of infectious and chronic diseases, and the expansion of the biosimilar market.
Competitive Landscape
Market players are providing contract packaging services to pharmaceutical manufacturers, ensuring efficient and reliable packaging solutions for medicines and healthcare products.
Other key players in the global pharmaceutical contract packaging market include Sharp Corporation, among others.
Global Pharmaceutical Contract Packaging Market Analysis by Region
United States leads the market share due to rising healthcare spending, which creates a demand for packaging solutions
The United States represents the world's largest market in pharmaceutical contract packaging, followed by China and India. The tremendous growth of pharmaceutical contract packaging market in United States is majorly driven by the rising healthcare spending, increasing geriatric population, and the increasing value of pharmaceutical exports. The growth is further driven by the high demand for innovative and specialised packaging solutions, the presence of leading pharmaceutical companies and contract packagers, and the stringent regulatory standards for quality and safety.
On the other hand, the pharmaceutical contract packaging market size in China is driven by the rapid growth of the pharmaceutical industry, the increasing outsourcing of packaging services, and the rising demand for biologics and biosimilars. According to pharmaceutical contract packaging market report, the Indian market is driven by the low-cost advantage, the availability of skilled labour, the increasing exports of generic drugs, and the growing domestic demand for pharmaceutical products.
Table of Contents
175 Pages
- 1 Executive Summary
- 1.1 Market Size 2024-2025
- 1.2 Market Growth 2025(F)-2034(F)
- 1.3 Key Demand Drivers
- 1.4 Key Players and Competitive Structure
- 1.5 Industry Best Practices
- 1.6 Recent Trends and Developments
- 1.7 Industry Outlook
- 2 Market Overview and Stakeholder Insights
- 2.1 Market Trends
- 2.2 Key Verticals
- 2.3 Key Regions
- 2.4 Supplier Power
- 2.5 Buyer Power
- 2.6 Key Market Opportunities and Risks
- 2.7 Key Initiatives by Stakeholders
- 3 Economic Summary
- 3.1 GDP Outlook
- 3.2 GDP Per Capita Growth
- 3.3 Inflation Trends
- 3.4 Democracy Index
- 3.5 Gross Public Debt Ratios
- 3.6 Balance of Payment (BoP) Position
- 3.7 Population Outlook
- 3.8 Urbanisation Trends
- 4 Country Risk Profiles
- 4.1 Country Risk
- 4.2 Business Climate
- 5 Global Pharmaceutical Contract Packaging Market Analysis
- 5.1 Key Industry Highlights
- 5.2 Global Pharmaceutical Contract Packaging Historical Market (2018-2024)
- 5.3 Global Pharmaceutical Contract Packaging Market Forecast (2025-2034)
- 5.4 Global Pharmaceutical Contract Packaging Market by Industry
- 5.4.1 Small Molecule
- 5.4.1.1 Historical Trend (2018-2024)
- 5.4.1.2 Forecast Trend (2025-2034)
- 5.4.2 Biopharmaceutical
- 5.4.2.1 Historical Trend (2018-2024)
- 5.4.2.2 Forecast Trend (2025-2034)
- 5.4.3 Vaccine
- 5.4.3.1 Historical Trend (2018-2024)
- 5.4.3.2 Forecast Trend (2025-2034)
- 5.5 Global Pharmaceutical Contract Packaging Market by Type
- 5.5.1 Sterile
- 5.5.1.1 Historical Trend (2018-2024)
- 5.5.1.2 Forecast Trend (2025-2034)
- 5.5.2 Non-Sterile
- 5.5.2.1 Historical Trend (2018-2024)
- 5.5.2.2 Forecast Trend (2025-2034)
- 5.6 Global Pharmaceutical Contract Packaging Market by Packaging
- 5.6.1 Plastic Bottles
- 5.6.1.1 Historical Trend (2018-2024)
- 5.6.1.2 Forecast Trend (2025-2034)
- 5.6.2 Caps and Closures
- 5.6.2.1 Historical Trend (2018-2024)
- 5.6.2.2 Forecast Trend (2025-2034)
- 5.6.3 Blister Packs
- 5.6.3.1 Historical Trend (2018-2024)
- 5.6.3.2 Forecast Trend (2025-2034)
- 5.6.4 Prefilled Syringes
- 5.6.4.1 Historical Trend (2018-2024)
- 5.6.4.2 Forecast Trend (2025-2034)
- 5.6.5 Parenteral Vials and Ampoules
- 5.6.5.1 Historical Trend (2018-2024)
- 5.6.5.2 Forecast Trend (2025-2034)
- 5.7 Global Pharmaceutical Contract Packaging Market by Region
- 5.7.1 United States
- 5.7.2 Europe
- 5.7.3 China
- 5.7.4 India
- 5.7.5 Others
- 6 Regional Analysis
- 6.1 United States
- 6.1.1 Historical Trend (2018-2024)
- 6.1.2 Forecast Trend (2025-2034)
- 6.2 Europe
- 6.2.1 Historical Trend (2018-2024)
- 6.2.2 Forecast Trend (2025-2034)
- 6.3 China
- 6.3.1 Historical Trend (2018-2024)
- 6.3.2 Forecast Trend (2025-2034)
- 6.4 India
- 6.4.1 Historical Trend (2018-2024)
- 6.4.2 Forecast Trend (2025-2034)
- 7 Market Dynamics
- 7.1 SWOT Analysis
- 7.1.1 Strengths
- 7.1.2 Weaknesses
- 7.1.3 Opportunities
- 7.1.4 Threats
- 7.2 Porter’s Five Forces Analysis
- 7.2.1 Supplier’s Power
- 7.2.2 Buyers Power
- 7.2.3 Threat of New Entrants
- 7.2.4 Degree of Rivalry
- 7.2.5 Threat of Substitutes
- 7.3 Key Indicators for Demand
- 7.4 Key Indicators for Price
- 8 Value Chain Analysis
- 9 Price Analysis
- 9.1 United States Historical Price Trends (2018-2024) and Forecast (2025-2034)
- 9.2 Europe Historical Price Trends (2018-2024) and Forecast (2025-2034)
- 9.3 China Historical Price Trends (2018-2024) and Forecast (2025-2034)
- 9.4 India Historical Price Trends (2018-2024) and Forecast (2025-2034)
- 10 Manufacturing Process
- 10.1 Detailed Process Flow
- 10.2 Operations Involved
- 10.3 Mass Balance and Raw Material
- 11 Project Details and Cost Analysis
- 11.1 Land, Location and Site Development
- 11.2 Construction
- 11.3 Plant Layout
- 11.4 Plant Machinery
- 11.5 Raw Material Requirement
- 11.6 Packaging
- 11.7 Transportation
- 11.8 Utilities
- 11.9 Manpower
- 11.10 Other Capital Investment
- 12 Loans and Financial Assistance
- 13 Project Economics
- 13.1 Capital Cost of Project
- 13.2 Techno-Economic Parameters
- 13.3 Product Pricing and Margins
- 13.4 Taxation and Depreciation
- 13.5 Income Projections
- 13.6 Expenditure Projections
- 13.7 Financial Analysis
- 14 Competitive Landscape
- 14.1 Supplier Selection
- 14.2 Key Global Players
- 14.3 Key Regional Players
- 14.4 Key Player Strategies
- 14.5 Company Profiles
- 14.5.1 Adelphi Healthcare Packaging
- 14.5.1.1 Company Overview
- 14.5.1.2 Product Portfolio
- 14.5.1.3 Demographic Reach and Achievements
- 14.5.1.4 Financial Summary
- 14.5.1.5 Certifications
- 14.5.2 Almac Group
- 14.5.2.1 Company Overview
- 14.5.2.2 Product Portfolio
- 14.5.2.3 Demographic Reach and Achievements
- 14.5.2.4 Financial Summary
- 14.5.2.5 Certifications
- 14.5.3 Berry Global Inc.
- 14.5.3.1 Company Overview
- 14.5.3.2 Product Portfolio
- 14.5.3.3 Demographic Reach and Achievements
- 14.5.3.4 Financial Summary
- 14.5.3.5 Certifications
- 14.5.4 PCI Services
- 14.5.4.1 Company Overview
- 14.5.4.2 Product Portfolio
- 14.5.4.3 Demographic Reach and Achievements
- 14.5.4.4 Financial Summary
- 14.5.4.5 Certifications
- 14.5.5 Sharp Corporation
- 14.5.5.1 Company Overview
- 14.5.5.2 Product Portfolio
- 14.5.5.3 Demographic Reach and Achievements
- 14.5.5.4 Financial Summary
- 14.5.5.5 Certifications
- 14.5.6 Others
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.